The Safety and Efficacy of Open-Source Artificial Pancreas System Among People With Type 1 Diabetes Mellitus in China
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the glycemic efficacy and potential related factors of the open-source APS.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Maximum Age: 75
Healthy Volunteers: f
View:
• diagnosed T1DM.
• Currently use open-source APS for at least 3 months.
• Willing and able to provide informed consent (or be a parent or other legally authorized representative) and to provide the data.
• reside in China.
Locations
Other Locations
China
Jinhua Yan
RECRUITING
Guangzhou
Contact Information
Primary
Jinhua Yan, PHD,MD
yanjh79@163.com
+8613929589959
Backup
Wen Xu, PHD,MD
xwen@mail.sysu.edu.cn
02085253000
Time Frame
Start Date: 2019-01-01
Estimated Completion Date: 2026-06-01
Participants
Target number of participants: 500
Treatments
open-source APS
open-source APS consisted of an insulin pump, a CGM system, and a heuristic algorithm on an Android smartphone.
Related Therapeutic Areas
Sponsors
Leads: Third Affiliated Hospital, Sun Yat-Sen University